GL1X · GenesisL1 explorer

MolNFT v1 · #28847 · protein

Escherichia COLI purine nucleoside phosphorylase II, the product of the xapa gene

1YQQ · Xanthosine phosphorylase: “Escherichia COLI purine nucleoside phosphorylase II, the product of the xapa gene”. X-ray diffraction, 2 ligands (GUN, PO4), 9 pockets (best druggability 0.86). MolNFT v1 #28847 on GenesisL1: 3D structure…

PDB
1YQQ
Type
protein
Length
819 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Xanthosine phosphorylase
EC
2.4.2.1
UniProt
P45563
Ligands
GUN, PO4
Pockets
9 · best druggability 0.86

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CXanthosine phosphorylase (EC 2.4.2.1)protein27333% helix, 25% strandP45563

Ligands and binding sites

  • GUN · Guanine · ligand · 3 copies · chains A, B, C
  • PO4 · Phosphate ion · ion · 3 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13140.860.9540empty
21190.800.9827GUN, PO4
31160.790.9825GUN, PO4
41080.790.9825GUN, PO4
52040.440.7329empty

Interfaces

3 interfaces between chains.

  • A–C · 998 Ų buried · 9 hydrogen bonds · protein-protein
  • B–C · 997 Ų buried · 8 hydrogen bonds · protein-protein
  • A–B · 964 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 1YQQ · Escherichia coli purine nucleoside phosphorylase II, the product of the xapA gene · the same entry in another collection · chain A against A, TM-score 1.00
  • P45563 · AlphaFold monomer V2.0 prediction for purine nucleoside phosphorylase 2 (P45563) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.